Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Clin Cancer Res. 2017 Sep 22;23(23):7199–7208. doi: 10.1158/1078-0432.CCR-17-1178

Figure 1. Study design.

Figure 1

(A) Overall hypothesis for the mechanism of action of entinostat in suppressing regulatory T cells (Treg) and expanding cytotoxic T-cells and natural killer cells (NK). (B) Clinical trial schema.